PAVmed Inc. — Director's Dealing 2022

Feb 24, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-02-22

Reporting Person: O'Neil Shaun (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	225000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee stock option (right to buy)	$1.58	2028-07-23	Common stock (195108)		Direct
Employee stock option (right to buy)	$1	2029-03-17	Common stock (100000)		Direct
Employee stock option (right to buy)	$4.44	2031-04-01	Common stock (75000)		Direct

Footnotes

F1: The issuer granted 225,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.

F2: All options vest 1/12 on the first calendar quarter end after the Grant Date (as defined below), then additional 1/12 on each successive calendar quarter. Fully vested after 12 quarters. "Grant Date" as used herein shall mean, for each respective option, the date that is exactly ten years earlier than the Expiration date for such option.